WANG HUIMIN

About WANG HUIMIN

Huimin Wang, M.D. is a long-tenured executive in the medical technology industry with a significant track record at Edwards Lifesciences. Public company disclosures identify him as Corporate Vice President, Japan, Asia and Pacific since 2010. Before that, he served as Corporate Vice President, Japan and Intercontinental Regions from 2004 to 2010, and as Corporate Vice President, Japan from 2000 to 2004. This progression suggests a career built around increasing responsibility for strategically important international markets, particularly across Asia-Pacific, where commercial execution, regulatory coordination, and local market knowledge are essential. Prior to joining Edwards Lifesciences, Dr. Wang held a number of roles at Baxter Healthcare Corporation. His Baxter experience included senior responsibilities in strategy development, product and therapy leadership for the Renal Division in Japan, and a leadership role as President of Medical Systems and Devices in Japan. He also served as representative director of Baxter Limited, the company’s Japanese entity. These positions indicate substantial experience in medical devices, regional business leadership, and managing complex operations in highly regulated healthcare environments. Dr. Wang’s background also includes work in consulting and clinical medicine, which adds depth to his executive profile. He served as a senior associate at Booz, Allen & Hamilton in Chicago, was vice president of Integrated Strategies, a consulting and venture management firm that he co-founded, and worked as an associate at McKinsey & Company. Earlier in his career, he was a resident and staff physician in anesthesiology at Keio University Hospital in Tokyo. That combination of clinical training, strategic advisory experience, and corporate leadership is notable because it often supports effective decision-making in global healthcare businesses. At Edwards, his responsibilities likely centered on regional growth, market development, organizational leadership, and supporting the company’s expansion in Japan and broader Asia-Pacific markets. His career reflects a blend of medical expertise, strategy, and international management, with particular strength in guiding business development in major Asian healthcare markets. His profile is especially relevant in the context of Edwards Lifesciences’ patient-focused and innovation-driven global business model.